VERICEL CORPORATION Restructuring Reserve
VERICEL CORPORATION (VCEL) had Restructuring Reserve of $0 as of 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2017-03-13
- 2016-12-31: Restructuring Reserve $0.00.
- 2015-12-31: Restructuring Reserve $0.00.
- 2015-09-30: Restructuring Reserve $0.00.
- 2015-06-30: Restructuring Reserve $0.00.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-13 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 | |
| 2014-09-30 | $900.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.60M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $100.00K 10-K · filed 2016-03-14 | $21.00K 10-K · filed 2014-03-13 |
| 2013-09-30 | $83.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $204.00K 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |